Recent 8-K filings for HIT

• May 13, 2026, 6:15 PM ET earnings materiality 0.15 neutral item 7.01item 9.01

  Health In Tech holds Q1 2026 earnings call; no financial figures disclosed in furnished transcript excerpt

  Company hosted conference call on May 13, 2026 to discuss Q1 2026 results.

• May 13, 2026, 5:30 PM ET other material materiality 0.70 negative item 7.01item 9.01

  Health In Tech Q1 revenue up 9% YoY to $8.8M; guides FY2026 revenue $45-50M; EBITDA turns negative on growth spend

  Q1 2026 total revenue $8.8M (+9% YoY); adjusted EBITDA -$1.3M vs. +$1.2M in Q1 2025.

• May 13, 2026, 4:21 PM ET earnings materiality 0.60 neutral item 2.02item 7.01item 9.01

  Health In Tech Q1 revenue up 9.4% to $8.8M; net loss of $1.6M vs prior year profit

  Revenue $8.8M (+9.4% YoY); net loss $1.6M ($0.03 diluted loss) vs net income $0.5M in Q1 2025.

• May 1, 2026, 7:59 PM ET leadership materiality 0.40 neutral item 5.02item 9.01 ◈ executive_change

  Dustin Plantholt exits as Chief AI & Marketing Officer; signs consulting deal with HITChain

  Dustin Plantholt departed as Chief AI & Marketing Officer effective Apr 30, 2026, as part of a business transition, not a disagreement.

• March 27, 2026, 7:59 PM ET other material materiality 0.65 positive item 1.01item 9.01

  Health In Tech closes $7.0M PIPE financing, issues 5.6M shares at $1.25/share

  Gross proceeds of $7.0M from private placement with institutional and accredited investors.

• March 27, 2026, 7:59 PM ET other material materiality 0.10 neutral item 7.01item 9.01

  Health In Tech furnishes investor presentation for conferences; no details available

  Company prepared an investor presentation for use at conferences and meetings as of March 25, 2026.

• March 26, 2026, 7:59 PM ET other material materiality 0.60 neutral item 1.01item 3.02item 7.01item 9.01 ◈ Material Agreements ×3

  Health In Tech raises $7.0M in PIPE at $1.25 per share

  Gross proceeds of ~$7.0 million from 5,600,000 shares at $1.25 per share.

• March 25, 2026, 7:59 PM ET earnings materiality 0.75 positive item 2.02item 7.01item 9.01

  Health In Tech reports FY2025 revenue $33.3M (+71% YoY); guides FY2026 $45-50M

  Full year 2025 revenue $33.3M (+71% YoY); net income $1.3M (+91%); Adjusted EBITDA $4.1M (+81%).

• December 2, 2025, 6:59 PM ET other material materiality 0.30 positive item 1.01item 7.01item 9.01

  Health In Tech executives voluntarily extend share lock-up through June 20, 2026

  Executive management, VPs, and Board voluntarily extended lock-up on all shares held.

• November 26, 2025, 6:59 PM ET leadership materiality 0.50 neutral item 5.02

  Health In Tech terminates CTO Imran Yousuf effective Nov 25, 2025

  Imran Yousuf terminated as CTO on November 25, 2025, without cause.

• November 12, 2025, 6:59 PM ET other material materiality 0.20 neutral item 7.01item 9.01

  Health In Tech furnishes investor presentation with no material details disclosed

  Investor presentation prepared for conferences was furnished on November 10, 2025.

• November 12, 2025, 6:59 PM ET earnings materiality 0.75 positive item 2.02item 7.01item 9.01

  Health In Tech Q3 revenue $8.5M (+90% YoY); nine-month revenue $25.8M, 132% of FY2024

  Revenue $8.5M, up 90% YoY; nine-month revenue $25.8M, 132% of full-year 2024.

• November 12, 2025, 6:59 PM ET earnings materiality 0.15 neutral item 7.01item 9.01

  Health In Tech holds Q3 2025 earnings call; transcript lacks financial details

  Company hosted Q3 2025 earnings conference call on November 10, 2025.

• October 6, 2025, 7:59 PM ET other material materiality 0.15 neutral item 5.07

  Health In Tech shareholders re-elect directors, approve equity plan amendment

  All five director nominees re-elected; votes in favor ranged from 147.9M to 148.0M.

• September 29, 2025, 7:59 PM ET other material materiality 0.35 neutral item 5.02

  Health In Tech awards 80k restricted shares each to CEO and CFO for new initiative

  CEO Tim Johnson and CFO Linlin (Julia) Qian each granted 80,000 restricted stock awards.

• August 19, 2025, 7:59 PM ET leadership materiality 0.25 neutral item 5.02

  Health In Tech grants restricted stock to CEO, CFO, CTO tied to two new programs

  CEO Tim Johnson granted 34,000 shares (17k each for Program 1 & 2).

• July 28, 2025, 7:59 PM ET leadership materiality 0.65 negative item 5.02

  Health In Tech terminates COO Chris Kurtenbach effective July 22, 2025

  Chris Kurtenbach's at-will employment as COO terminated by board on July 22, 2025.

• July 21, 2025, 7:59 PM ET earnings materiality 0.75 positive item 2.02item 7.01item 9.01

  Health In Tech Q2 revenue $9.3M (+86% YoY), adj. EBITDA $1.6M (+134% YoY)

  Revenue $9.3M, up 86% YoY; first-half revenue $17.3M, 89% of full-year 2024.

• July 21, 2025, 7:59 PM ET other materiality 0.10 neutral item 7.01item 9.01

  Health In Tech files investor presentation; no material new financial data disclosed

  Company furnished investor presentation for conferences.

• April 29, 2025, 7:59 PM ET regulatory materiality 0.75 negative item 3.01

  Health In Tech receives Nasdaq bid-price deficiency notice; 180 days to cure

  On April 28, 2025, Nasdaq notified Health In Tech that its Class A common stock (HIT) failed to maintain minimum $1.00 bid price for 30 consecutive business days.

• April 17, 2025, 7:59 PM ET leadership materiality 0.25 neutral item 5.02 ◈ executive_change

  Director Lynn Liang resigns from Health In Tech board effective April 18, 2025

  Lynn Liang resigns from Board and Compensation Committee effective April 18, 2025.

• April 14, 2025, 7:59 PM ET earnings materiality 0.75 positive item 2.02item 7.01item 9.01

  Health In Tech Q1 rev $8.0M (+56% YoY); pretax income triples to $0.7M

  Revenue $8.0M, up 56% YoY; income before tax $0.7M (+257%); adjusted EBITDA $1.2M (vs $0.5M).

• April 14, 2025, 7:59 PM ET other material materiality 0.10 neutral item 7.01item 9.01

  Health In Tech files investor presentation; no material new information disclosed

  Company furnished investor presentation for conferences and meetings on April 14, 2025.

• April 10, 2025, 7:59 PM ET leadership materiality 0.50 neutral item 5.02item 7.01item 9.01 ◈ executive_change

  Health In Tech appoints Sanjay Shrestha to board, expands to 7 directors

  Board expanded from 6 to 7; Shrestha elected April 8, 2025 for one-year term.

• March 17, 2025, 7:59 PM ET earnings materiality 0.70 negative item 2.02item 7.01item 9.01

  Health In Tech FY2024 revenue $19.5M (+1.8%); adj. EBITDA falls to $2.3M from $4.8M; leadership reshuffled

  Full-year 2024 revenue $19.5M (+1.8% YoY); income from continuing ops $0.7M vs $2.5M in 2023.

• March 17, 2025, 7:59 PM ET other material materiality 0.10 neutral item 7.01item 9.01

  Health In Tech files investor presentation with no material new data

  Investor presentation furnished as Exhibit 99.1, intended for use at conferences and meetings.

• February 27, 2025, 6:59 PM ET other materiality 0.30 neutral item 5.03item 9.01

  Health In Tech board increases authorized directors from 7 to 11, adopts new term structure

  Board adopted Third Amended and Restated Bylaws on February 25, 2025.

• December 26, 2024, 6:59 PM ET other material materiality 0.80 positive item 1.01item 7.01item 9.01

  Health In Tech completes IPO of 2.3M shares at $4.00, raising $9.2M gross

  Priced IPO of 2,300,000 Class A shares at $4.00 per share on Dec 20, 2024.

Executive changes

Earnings & guidance

Materiality & sentiment trend

Max materiality 0.80 · Median 0.45 · Most common event other_material

7 positive 4 negative 17 neutral

source · HIT on sec.gov